-
公开(公告)号:US20080227788A9
公开(公告)日:2008-09-18
申请号:US10965182
申请日:2004-10-14
申请人: Patricia Beck , Cara Cesario , Matthew Cox , Han-Qing Dong , Kenneth Foreman , Mark Mulvihill , Anthony Nigro , Lydia Saroglou , Arno Steinig , Yingchuan Sun , Qinghua Weng , Douglas Werner , Robin Wilkes , Jonathan Williams
发明人: Patricia Beck , Cara Cesario , Matthew Cox , Han-Qing Dong , Kenneth Foreman , Mark Mulvihill , Anthony Nigro , Lydia Saroglou , Arno Steinig , Yingchuan Sun , Qinghua Weng , Douglas Werner , Robin Wilkes , Jonathan Williams
IPC分类号: A61K31/498 , C07D487/04
CPC分类号: C07D487/04
摘要: Compounds of the formula and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
摘要翻译: 式I化合物及其药学上可接受的盐,其中Q 1和R 1在本文中定义,抑制IGF-1R酶,并且可用于治疗和/或预防 通过抑制酪氨酸激酶对治疗作出反应的各种疾病和病症。
-
公开(公告)号:US20090181940A1
公开(公告)日:2009-07-16
申请号:US12175801
申请日:2008-07-18
申请人: Patricia Anne Beck , Cara Cesario , Matthew Cox , Han-Qing Dong , Kenneth Foreman , Mark Joseph Mulvihill , Anthony Innocenzo Nigro , Lydia Saroglou , Arno G. Steinig , Yingchuan Sun , Qinghua Weng , Douglas Werner , Wilkes Robin , Williams Jonathan
发明人: Patricia Anne Beck , Cara Cesario , Matthew Cox , Han-Qing Dong , Kenneth Foreman , Mark Joseph Mulvihill , Anthony Innocenzo Nigro , Lydia Saroglou , Arno G. Steinig , Yingchuan Sun , Qinghua Weng , Douglas Werner , Wilkes Robin , Williams Jonathan
IPC分类号: A61K31/397 , C07D241/36 , C07D295/00 , C07D223/02 , A61P1/04 , A61P31/00 , A61P27/02 , A61P29/00 , A61P33/02 , A61K31/55 , A61K31/5377 , A61K31/4985
CPC分类号: C07D487/04
摘要: Compounds of the formula and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
摘要翻译: 其中Q1和R1在本文中定义的式和其药学上可接受的盐的化合物抑制IGF-1R酶,并且可用于治疗和/或预防通过抑制酪氨酸激酶对治疗作出反应的各种疾病和病症。
-
公开(公告)号:US07323596B2
公开(公告)日:2008-01-29
申请号:US10433625
申请日:2001-12-21
申请人: Barry Porter , Paul Gane , Raymond Beckett , Kenneth Keavey , Jac Wijkmans , Lydia Saroglou
发明人: Barry Porter , Paul Gane , Raymond Beckett , Kenneth Keavey , Jac Wijkmans , Lydia Saroglou
IPC分类号: C07C239/00 , C07C259/00 , C07C303/00 , C07C307/00 , C07C309/00 , C07C311/00
CPC分类号: C07D285/10 , C07C259/06 , C07C311/19 , C07D209/18 , C07D215/56 , C07D217/22 , C07D263/12 , C07D311/12 , C07D491/04
摘要: Compounds of formula (I) and (IA) have antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH(═O) or of formula C(═O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of formula N(OH)CH(═O), a hydroxy or amino group; R2 represents a radical of formula R10—(X)n-(ALK)m- wherein R10 represents hydrogen, or an optionally substituted c1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, cycloalkyl, aryl, or heterocyclyl group, ALK represents a straight or branched divalent C1-C6 alkylene, C2-C6 ?alkenylene, or C2-C6 alkynylene radical, and may be interrupted by one or more non-adjacent NH—, —O— or S— linkages, X represents NH—, —O— or S—, and m and n are independently 0 or 1; R3 represents hydrogen, C1-C6alkyl, or benzyl; and R4 is as defined in the specification.
摘要翻译: 式(I)和(IA)的化合物具有抗菌或抗原虫活性:式(1)式(2)其中:Z表示式N(OH)CH(-O)或式C(-O)NH (哦); R 1表示氢,甲基或三氟甲基,或除Z是式N(OH)CH(-O),羟基或氨基基团时; R 2表示式R 10 - (X)n - (ALK)m - 的基团,其中R C 1 -C 10烷基,C 2 -C 6烷基,C 2 -C 6烷基,C 1 -C 6烷基,C 1 -C 6烷基, 6个烯基,C 2 -C 6炔基,环烷基,芳基或杂环基,ALK表示直链或支链二价C 1 - “C” - “C” - “00”“”=“2.46mm”wi =“1.44mm”file = “US07323596-20080129-P00001.TIF”alt =“自定义字符”img-content =“character”img-format =“tif”/> 6亚链烯基或C 2 -C 6个亚炔基,并且可以被一个或多个不相邻的NH-,-O-或S-键间隔,X表示NH-,-O-或S-,m和n独立地为0或 1; R 3表示氢,C 1 -C 6烷基或苄基; R 4和R 4如本说明书中所定义。
-
公开(公告)号:US20060084654A1
公开(公告)日:2006-04-20
申请号:US10965182
申请日:2004-10-14
申请人: Patricia Beck , Cara Cesario , Matthew Cox , Han-Qing Dong , Kenneth Foreman , Mark Mulvihill , Anthony Nigro , Lydia Saroglou , Arno Steinig , Yingchuan Sun , Qinghua Weng , Douglas Werner , Robin Wilkes , Jonathan Williams
发明人: Patricia Beck , Cara Cesario , Matthew Cox , Han-Qing Dong , Kenneth Foreman , Mark Mulvihill , Anthony Nigro , Lydia Saroglou , Arno Steinig , Yingchuan Sun , Qinghua Weng , Douglas Werner , Robin Wilkes , Jonathan Williams
IPC分类号: A61K31/498 , C07D487/04
CPC分类号: C07D487/04
摘要: Compounds of the formula and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
摘要翻译: 式I化合物及其药学上可接受的盐,其中Q 1和R 1在本文中定义,抑制IGF-1R酶,并且可用于治疗和/或预防 通过抑制酪氨酸激酶对治疗作出反应的各种疾病和病症。
-
公开(公告)号:US20050182137A1
公开(公告)日:2005-08-18
申请号:US10497495
申请日:2002-11-27
申请人: Paul Gane , Barry Porter , Lydia Saroglou , Henriette Willems , Jac Wijkmans
发明人: Paul Gane , Barry Porter , Lydia Saroglou , Henriette Willems , Jac Wijkmans
IPC分类号: A61P31/04 , C07C259/06 , A61K31/44 , A61K31/19 , C07C259/04
CPC分类号: C07C259/06 , C07C2601/08 , C07C2601/14 , C07C2602/08
摘要: Compounds of formula (I), are antibacterial agents, wherein: Z represents a radical formula —N(OH)CH(═O) or of formula —C(═O)NH(OH); X represents a straight or branched divalent C1-C6 alkenylene, or C2-C6 alkynylene radical; n is O or 1; and R represents an optionally substituted carbocyclic or heterocyclic group.
摘要翻译: 式(I)化合物是抗菌剂,其中:Z表示基团式-N(OH)CH(-O)或式-C( - O)NH(OH)); X表示直链或支链二价C 1 -C 6亚烯基或C 2 -C 6亚炔基 ; n为0或1; 并且R表示任选取代的碳环或杂环基。
-
-
-
-